CFO Keith Marchiando resigns; William Sullivan appointed Interim CFO

Zivo Bioscience, Inc.

Keith Marchiando resigns as CFO effective Dec 31, 2025; receives $27,040/mo through Dec 31, 2026.
Marchiando retains option for 150,000 shares at $7.96, exercisable until June 30, 2027; all other options cancelled.
William A. Sullivan appointed Interim CFO effective Dec 19, 2025 as independent contractor at $285/hour.
Sullivan's contract is initially 60 days, auto-renewing monthly; no other compensation or equity.
Marchiando's separation includes confidentiality and non-disparagement obligations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.